Heart disease remains the leading cause of death, yet most heart attacks and strokes are preceded by years—often decades—of silent change. The good news is that many of these changes can be detected and addressed long before they become emergencies.
In this gathering, we'll move beyond the simplistic idea of "good" and "bad" cholesterol to understand what common lipid tests do—and don't—tell us about cardiovascular risk. We'll discuss when additional markers like ApoB and Lipoprotein(a) may provide a clearer picture, and why context matters more than any single lab value.
We'll also explore the role of family history. When should a parent's heart attack change your approach? How much of your future is written in your genes, and how much can still be influenced by your daily choices?
Finally, we'll discuss when imaging becomes useful. Coronary artery calcium (CAC) scans, carotid ultrasound, and other tools can sometimes reveal hidden disease before symptoms appear—but they're not necessary for everyone. We'll talk about who benefits, who doesn't, and how these tests fit into a thoughtful, evidence-based approach to prevention.
As always, the goal isn't to create fear or chase endless testing. It's to understand your trajectory, identify meaningful opportunities to lower risk, and make informed decisions that help you protect both the length and quality of your life.
You'll leave with a clearer understanding of:
How heart disease develops years before symptoms appear
Which cholesterol markers deserve your attention—and which require context
How family history should (and shouldn't) influence your decisions
When imaging can provide valuable information about hidden cardiovascular disease
Practical steps to reduce risk without becoming overwhelmed by data
This session builds on our previous conversations about proactive health by asking one simple question: How do we protect the heart before it ever asks for help?